GR77073B - - Google Patents

Info

Publication number
GR77073B
GR77073B GR70190A GR820170190A GR77073B GR 77073 B GR77073 B GR 77073B GR 70190 A GR70190 A GR 70190A GR 820170190 A GR820170190 A GR 820170190A GR 77073 B GR77073 B GR 77073B
Authority
GR
Greece
Prior art keywords
lower alkyl
compounds
radical
salts
substituted
Prior art date
Application number
GR70190A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of GR77073B publication Critical patent/GR77073B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Oxygen, Ozone, And Oxides In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
GR70190A 1981-12-30 1982-12-30 GR77073B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH835981 1981-12-30
CH225582 1982-04-14

Publications (1)

Publication Number Publication Date
GR77073B true GR77073B (el) 1984-09-05

Family

ID=25689928

Family Applications (1)

Application Number Title Priority Date Filing Date
GR70190A GR77073B (el) 1981-12-30 1982-12-30

Country Status (18)

Country Link
US (1) US4497808A (el)
EP (1) EP0083315B1 (el)
AT (1) ATE28643T1 (el)
AU (1) AU556201B2 (el)
CA (1) CA1215053A (el)
DD (1) DD209456A5 (el)
DE (1) DE3276862D1 (el)
DK (1) DK580282A (el)
ES (4) ES8405783A1 (el)
FI (1) FI824531L (el)
GB (1) GB2112782B (el)
GR (1) GR77073B (el)
HU (1) HU192760B (el)
IE (1) IE54496B1 (el)
IL (1) IL67602A0 (el)
NO (1) NO824420L (el)
NZ (1) NZ202959A (el)
PT (1) PT76057B (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0111453A1 (de) * 1982-12-10 1984-06-20 Ciba-Geigy Ag Amid-Verbindungen
EP0125803A3 (en) * 1983-04-27 1987-01-21 FISONS plc Pharmaceutically active dihydropyridines
DE3410645A1 (de) * 1984-03-23 1985-09-26 Bayer Ag, 5090 Leverkusen L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
US5326772A (en) * 1984-09-28 1994-07-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Diaryl compounds for their use
JPH0676405B2 (ja) * 1986-06-13 1994-09-28 日清製粉株式会社 １，４―ジヒドロピリジン誘導体およびそれを含有する医薬組成物
US4833150A (en) * 1985-03-14 1989-05-23 Nelson Research & Development Co. 1,4-dihydropyridines
IT1215298B (it) * 1985-08-06 1990-01-31 Boehringer Biochemia Srl 2-(eteroalchil)-1,4-diidropiridine ed un processo per la loro produzione.
DE3601397A1 (de) * 1986-01-18 1987-07-23 Bayer Ag Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
WO1988007525A1 (fr) * 1987-03-27 1988-10-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Enantiomeres de 1,4-dihydropyridine
US5158963A (en) * 1989-08-02 1992-10-27 Kaken Pharmaceutical Co., Ltd. 1-4-dihydropyridine derivative, process for preparing the same and pharmaceutical composition containing the same
EP1663227A2 (en) * 2003-09-10 2006-06-07 Synta Pharmaceuticals Corporation Dihydropyridine compounds for treating or preventing metabolic disorders
USD1044219S1 (en) * 2021-06-04 2024-10-01 Crocs, Inc. Footwear

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792765A1 (de) * 1965-11-10 1974-10-10 Bayer Ag Verwendung von dihydrodipyridylen als kreislaufbeeinflussende mittel
DE1545873A1 (de) * 1965-11-10 1970-02-26 Bayer Ag Verfahren zur Herstellung von Dihydrodipyridylderivaten
DE2003146A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
US3862161A (en) * 1970-01-24 1975-01-21 Bayer Ag 4-pyridyl substituted 1,4-dihydropyridines
US3966948A (en) * 1970-01-24 1976-06-29 Bayer Aktiengesellschaft Spasmolytic, vaso-dilating and anti-hypertensive compositions and methods
US3920823A (en) * 1972-03-06 1975-11-18 Bayer Ag Use of unsymmetrical esters of n-substituted 1,4-dihydropyridine 3,5-dicarboxylic acid as cardio-vascular agents
US3933834A (en) * 1972-03-06 1976-01-20 Bayer Aktiengesellschaft Unsymmetrical esters of N-substituted 1,4-dihydropyridine 3,5-dicarboxylic acid
DE2210672C3 (de) * 1972-03-06 1980-03-20 Bayer Ag, 5090 Leverkusen N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2228377A1 (de) * 1972-06-10 1974-01-03 Bayer Ag Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2248150A1 (de) * 1972-09-30 1974-04-04 Bayer Ag Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US3946027A (en) * 1972-09-30 1976-03-23 Bayer Aktiengesellschaft 3,5,6-Tricarboxy-4-pyridyl-1,4-dihydropyridine derivatives
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
DE2616991A1 (de) * 1976-04-17 1977-10-27 Bayer Ag Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
ES530653A0 (es) 1985-12-16
ES530655A0 (es) 1985-12-01
FI824531A7 (fi) 1983-07-01
CA1215053A (en) 1986-12-09
IE823092L (en) 1983-06-30
AU9195982A (en) 1983-07-07
US4497808A (en) 1985-02-05
DK580282A (da) 1983-07-01
ATE28643T1 (de) 1987-08-15
FI824531L (fi) 1983-07-01
ES518711A0 (es) 1984-06-16
NO824420L (no) 1983-07-01
NZ202959A (en) 1985-11-08
IL67602A0 (en) 1983-05-15
ES8405783A1 (es) 1984-06-16
ES8603456A1 (es) 1985-12-16
EP0083315A2 (de) 1983-07-06
PT76057A (en) 1983-01-01
DD209456A5 (de) 1984-05-09
GB2112782B (en) 1985-05-01
FI824531A0 (fi) 1982-12-30
EP0083315A3 (en) 1983-08-24
GB2112782A (en) 1983-07-27
HU192760B (en) 1987-07-28
ES8602666A1 (es) 1985-12-01
PT76057B (en) 1986-02-04
ES8701160A1 (es) 1986-11-16
AU556201B2 (en) 1986-10-23
DE3276862D1 (en) 1987-09-03
IE54496B1 (en) 1989-10-25
ES530654A0 (es) 1986-11-16
EP0083315B1 (de) 1987-07-29

Similar Documents

Publication Publication Date Title
GB2112782B (en) N-oxide compounds, processes for their manufacture and pharmaceutical compositions containing them
IL87184A0 (en) Polyethylene glycol carbamates,their manufacture and pharmaceutical and diagnostic compositions containing them
EP0143746A3 (de) Substituierte 5-Amino-4-hydroxyvalerylderivate
BG60030B2 (bg) Метод за получаване на (d)-алфа-етил-2-оксо-1- пиролидинацетамид
IL73893A (en) 11-aryl-13-estradiene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
ATE106245T1 (de) Anwendung von monoaminakridinen bei mangelerscheinungen des cholinergen nervensystems.
IE811697L (en) Pyridyl thiazolines
AR003414A1 (es) Uso de derivados de imidazol [1,2-a]piridina -3-acetamida y una composicion farmaceutica que comprende tal derivado
ES479933A1 (es) Un procedimiento para la preparacion de derivados de amino- piridina.
NL7603947A (nl) Werkwijze voor de bereiding van fenylalkaancar- bonzuurderivaten.
FR2506771A1 (fr) Derives de carboximide, procedes pour leur preparation et medicament les contenant
ATE159514T1 (de) Substituierte aminsäure derivate verwendbar für die behandlung von arteriosclerosis
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
HUT44515A (en) Process for producing isoquinolinol compounds of heart activity increasing, phosphodiesterase iii inhibiting and/or renal vasodilating activity and pharmaceutical composition containing them
ES2000865A6 (es) Procedimiento para la obtencion de derivados del acido 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilico
PT79158A (fr) Derives de nitrosourees leur procede de preparation et compositions pharmaceutiques les contenant
FR2493846B1 (el)
ATE12238T1 (de) Neue ketale von 3'''-dehydro-cardenolidtridigitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE22683T1 (de) Substituiertes heterocyclylphenylsulphonyl und phosphonylamidine, verfahren zu deren herstellung und deren pharmazeutische anwendung.
ES8602020A1 (es) Un procedimiento para la produccion de derivados de imidazo (2,1-b) tiazol